Related Experiment Video
Updated: Mar 22, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
Glucocorticoids Hijack Runx2 to Stimulate Wif1 for Suppression of Osteoblast Growth and Differentiation
Eri Morimoto1, Meng Li2, Aysha B Khalid3
1Departments of Biochemistry and Molecular Biology, Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Abstract:
Inhibition of Runx2 is one of many mechanisms that suppress bone formation in glucocorticoid (GC)-induced osteoporosis (GIO). We profiled mRNA expression in ST2/Rx2(dox) cells after treatment with doxycycline (dox; to induce Runx2) and/or the synthetic GC dexamethasone (dex). As expected, dex typically antagonized Runx2-driven transcription. Select genes, however, were synergistic stimulated and this was confirmed by RT-qPCR. Among the genes synergistically stimulated by GCs and Runx2 was Wnt inhibitory Factor 1 (Wif1), and Wif1 protein was readily detectable in medium conditioned by cultures co-treated with dox and dex, but neither alone. Cooperation between Runx2 and GCs in stimulating Wif1 was also observed in primary preosteoblast cultures. GCs strongly inhibited dox-driven alkaline phosphatase (ALP) activity in control ST2/Rx2(dox) cells, but not in cells in which Wif1 was silenced. Unlike its anti-mitogenic activity in committed osteoblasts, induction of Runx2 transiently increased the percentage of cells in S-phase and accelerated proliferation in the ST2 mesenchymal pluripotent cell culture model. Furthermore, like the inhibition of Runx2-driven ALP activity, dex antagonized the transient mitogenic effect of Runx2 in ST2/Rx2(dox) cultures, and this inhibition eased upon Wif1 silencing. Plausibly, homeostatic feedback loops that rely on Runx2 activation to compensate for bone loss in GIO are thwarted, exacerbating disease progression through stimulation of Wif1. J. Cell. Physiol. 232: 145-153, 2017. © 2016 Wiley Periodicals, Inc.
Insights
Glucocorticoids (GCs) and Runx2 synergistically stimulate Wnt inhibitory Factor 1 (Wif1), exacerbating osteoporosis. Silencing Wif1 partially reverses GC-induced inhibition of bone formation markers and Runx2
Area of Science:
- Molecular biology
- Cell biology
- Endocrinology
Background:
- Glucocorticoid-induced osteoporosis (GIO) involves suppressed bone formation.
- Runx2 is a key transcription factor in bone formation, and its inhibition is a mechanism in GIO.
Purpose of the Study:
- To investigate the interplay between glucocorticoids (GCs) and Runx2 in regulating gene expression and cellular processes relevant to bone formation.
- To identify specific genes synergistically regulated by GCs and Runx2.
Main Methods:
- mRNA expression profiling in ST2/Rx2(dox) cells treated with doxycycline (dox) and/or dexamethasone (dex).
- Validation of gene expression using RT-qPCR.
- Detection of Wnt inhibitory Factor 1 (Wif1) protein.
- Assessment of alkaline phosphatase (ALP) activity.
- Cell proliferation assays (S-phase percentage).
- Wif1 silencing experiments.
Main Results:
- Dexamethasone (dex) antagonized most Runx2-driven transcription, but synergistically stimulated select genes.
- Wnt inhibitory Factor 1 (Wif1) was identified as a gene synergistically stimulated by GCs and Runx2, with Wif1 protein detected upon co-treatment.
- GCs inhibited Runx2-driven alkaline phosphatase (ALP) activity, an effect blunted by Wif1 silencing.
- Runx2 induction transiently increased proliferation in ST2 cells, an effect inhibited by dex, which was partially reversed by Wif1 silencing.
Conclusions:
- Cooperation between Runx2 and GCs stimulates Wif1, potentially thwarting compensatory Runx2 activation in GIO and exacerbating disease progression.
- Wif1 plays a role in mediating the inhibitory effects of GCs on Runx2-driven osteogenic differentiation and proliferation.
More Related Videos
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
TGF - β Signaling Pathway
Master Transcription Regulators
Osteoclasts in Bone Remodeling
Non-Canonical Wnt Signaling Pathways